Glenmark Pharmaceuticals Schedules Board Meeting for Q2 FY27 Results
Glenmark Pharmaceuticals Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Glenmark Pharmaceuticals Schedules Board Meeting for Q2 FY27 Results Glenmark Pharmaceuticals Limited will hold a Board of Directors meeting on 5th Nov'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for designated persons and insiders, which closed on 1st Oct'26, will remain shut until 7th Nov'26 and reopen on 8th Nov'26, in compliance with SEBI insider trading regulations.
Original exchange filing (PDF)
More announcements from Glenmark Pharmaceuticals Ltd
- Ichnos Glenmark Innovation (IGI) announces IND submission to US FDA for ISB 2301 路 18 Nov 2026
- Glenmark Pharmaceuticals Inc., USA Launches Authorised Generic of INLYTA (axitinib) Tablets, 1 mg and 5mg 路 16 Nov 2026
- Schedule of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Initmation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst / Institutional Investor Meetings 路 10 Nov 2026
- Transcript of the Earnings Call 路 09 Nov 2026
- Audio recording of Q2 FY 2026-27 Earnings Call held on November 06, 2026 路 06 Nov 2026
